Literature DB >> 30216477

Outcomes of multidisciplinary treatment planning in US cancer care settings.

Irene Prabhu Das1, Melanie Baker1, Cheryl Altice1,2, Kathleen M Castro1, Barbara Brandys3, Sandra A Mitchell1.   

Abstract

Multidisciplinary treatment planning (MTP) is a process of engaging multiple disciplines to develop or refine the disease management plan. It is widely implemented in US cancer treatment settings and is considered to have favorable effects on both care quality and other outcomes. However, evidence reviews to date regarding MTP effectiveness have based their conclusions on studies conducted predominantly outside the United States. The authors conducted a systematic review of US-based studies to synthesize and critically appraise evidence of the effects of MTP on cancer care quality, health services outcomes, and survival. Database searches identified studies of MTP outcomes conducted in US cancer care settings from 2000 to 2017. Forty-five studies met criteria for inclusion. MTP was associated with favorable effects on several indicators of cancer care quality, including delivery of guideline-concordant treatment and improvements in diagnostic accuracy, staging completeness, surgical technique, and timeliness. Effects on survival and clinical trials enrollment were mixed. Delivery formats for MTP were generally not well described, and study designs were nonrandomized, limiting the ability to identify mediators of intervention effects. Continued study is warranted to clarify effective components of MTP interventions, and to understand the mechanism(s) through which MTP produces favorable effects on outcomes. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  cancer; multidisciplinary care; outcomes; quality of care; treatment planning

Mesh:

Year:  2018        PMID: 30216477     DOI: 10.1002/cncr.31394

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Rurality, Stage-Stratified Use of Treatment Modalities, and Survival of Non-small Cell Lung Cancer.

Authors:  Meredith A Ray; Nicholas R Faris; Anna Derrick; Matthew P Smeltzer; Raymond U Osarogiagbon
Journal:  Chest       Date:  2020-05-06       Impact factor: 9.410

2.  "All boats will rise": Physicians' perspectives on multidisciplinary lung cancer care in a community-based hospital setting.

Authors:  Satish K Kedia; Kenneth D Ward; Andy C Collins; Bianca M Jackson; Fedoria Rugless Stewart; Nicholas R Faris; Kristina S Roark; Raymond U Osarogiagbon
Journal:  Support Care Cancer       Date:  2019-07-15       Impact factor: 3.603

3.  A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool.

Authors:  Tayana Soukup; Abigail Morbi; Benjamin W Lamb; Tasha A K Gandamihardja; Katy Hogben; Katia Noyes; Ted A Skolarus; Ara Darzi; Nick Sevdalis; James S A Green
Journal:  Cancer Med       Date:  2020-05-31       Impact factor: 4.452

Review 4.  Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps.

Authors:  Nicole M Rankin; Elizabeth A Fradgley; David J Barnes
Journal:  Transl Lung Cancer Res       Date:  2020-08

5.  Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.

Authors:  T Konert; W V Vogel; D Paez; A Polo; E Fidarova; H Carvalho; P S Duarte; A C Zuliani; A O Santos; D Altuhhova; L Karusoo; R Kapoor; A Sood; J Khader; A Al-Ibraheem; Y Numair; S Abubaker; C Soydal; T Kütük; T A Le; N X Canh; B Q Bieu; L N Ha; J S A Belderbos; M P MacManus; D Thorwarth; G G Hanna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-31       Impact factor: 9.236

Review 6.  Models of Integration of Specialized Palliative Care with Oncology.

Authors:  Jean Mathews; Breffni Hannon; Camilla Zimmermann
Journal:  Curr Treat Options Oncol       Date:  2021-04-08

7.  Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre.

Authors:  Raja Bhaskara Rajasekaran; Duncan Whitwell; Thomas D A Cosker; Christopher L M H Gibbons; Andrew Carr
Journal:  BMC Musculoskelet Disord       Date:  2021-01-05       Impact factor: 2.362

8.  Survival Impact of an Enhanced Multidisciplinary Thoracic Oncology Conference in a Regional Community Health Care System.

Authors:  Meredith A Ray; Nicholas R Faris; Carrie Fehnel; Anna Derrick; Matthew P Smeltzer; Meghan B Meadows-Taylor; Folabi Ariganjoye; Alicia Pacheco; Robert Optican; Keith Tonkin; Jeffrey Wright; Roy Fox; Thomas Callahan; Edward T Robbins; William Walsh; Philip Lammers; Shailesh Satpute; Raymond U Osarogiagbon
Journal:  JTO Clin Res Rep       Date:  2021-07-03

Review 9.  What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond.

Authors:  Michael Baumann; Nadja Ebert; Ina Kurth; Carol Bacchus; Jens Overgaard
Journal:  Mol Oncol       Date:  2020-06-30       Impact factor: 6.603

10.  Impact of optional multidisciplinary tumor board meeting on the mortality of patients with gastrointestinal cancer: A retrospective observational study.

Authors:  Mohammed Basendowah; Alaa M Awlia; Hanin A Alamoudi; Hala M Ali Kanawi; Abdulaziz Saleem; Nadim Malibary; Hussam Hijazi; Mohammed Alfawaz; Anas H Alzahrani
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.